Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 70.60M P/E - EPS this Y 38.30% Ern Qtrly Grth -
Income -52.6M Forward P/E -1.45 EPS next Y 5.10% 50D Avg Chg -19.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -3.00%
Dividend N/A Price/Book 3.06 EPS next 5Y - 52W High Chg -45.00%
Recommedations 1.60 Quick Ratio 7.38 Shares Outstanding 43.31M 52W Low Chg 46.00%
Insider Own 5.06% ROA -37.81% Shares Float 27.98M Beta 1.51
Inst Own 79.70% ROE -127.38% Shares Shorted/Prior 2.63M/3.03M Price 3.20
Gross Margin - Profit Margin - Avg. Volume 178,604 Target Price 15.92
Oper. Margin - Earnings Date Nov 11 Volume 108,439 Change -3.32%
About Abeona Therapeutics Inc.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.

Abeona Therapeutics Inc. News
11/19/24 ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50…
11/15/24 Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
11/14/24 Abeona Therapeutics: Q3 Earnings Snapshot
11/14/24 Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
11/12/24 Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
11/04/24 Abeona Therapeutics® Announces Participation in November Investor Conferences
11/01/24 Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/29/24 Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
10/09/24 Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...
09/03/24 Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
08/14/24 ABEO: Type A Meeting with FDA Concluded; BLA Submission on Track for 2H24…
08/14/24 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
08/13/24 Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
08/12/24 Abeona Therapeutics: Q2 Earnings Snapshot
08/12/24 Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
07/21/24 Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)
07/11/24 Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
07/08/24 Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
06/21/24 Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)
05/28/24 Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
ABEO Chatroom

User Image TheDegenerate1 Posted - 14 hours ago

$ABEO hopefully this can trend upward for the next couple months. Unlikely to see $8 before eoy imo, who’s to say what it will reach next year.

User Image Bob_C Posted - 1 day ago

$ENVX - New article on 10 small caps that are ready to explode... Let me add: $ABEO - their BLA was approved and PFUDA is in May $SAVA - P3 readout is EOY for Alzheimer's - NOTE anything close to their P2 OL results will be approved! https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-mourns-death-board-member-and-officer-nadav

User Image edelhead Posted - 1 day ago

$ABEO I believe that FDA approval will come well before late April. And I believe that management thinks so too; please listen to that part of the Stifel call on Monday. If an earlier approval happens, along with the awarding of a prv, the shorts will be caught off-guard and I could easily a short squeeze taking place!

User Image JimiJoJeeter Posted - 1 day ago

$ABEO in da green....

User Image fede5910 Posted - 1 day ago

$ABEO To the FDA authorities, do they need 5 more months to approve what was presented by ABEONA? If you have already seen almost everything, I made a CRL, they punished ABEO, what they asked for was corrected, which I understand was the only thing that was missing, Maybe 5 more months we have to wait, or rather the patients have to wait. Maybe someone will be interested in this time dilation. I have the feeling that the Kristal company had the fastest time from the FDA to obtain approval.

User Image EMINENZ Posted - 1 day ago

$ABEO should go back to pre CRL levels. 8$.

User Image type12 Posted - 2 days ago

$ABEO Typical 🚀🚀🚀

User Image JimiJoJeeter Posted - 2 days ago

$ABEO FFS.... volume is pathetic 😔

User Image edelhead Posted - 2 days ago

$ABEO Well written update from Zack's Research, increasing the price target from $7.50 to $9.50! The article is on yahoo finance under Abeo.

User Image JimiJoJeeter Posted - 2 days ago

$ABEO With $RARE BLA news on deck b4 EOY, I'm surprised we're not higher; but, it's a good entry point...

User Image alcacer123 Posted - 2 days ago

$ABEO The new FDA authorities accuse this FDA of corruption, which is totally true. They will sustain the very long approval period requested by the old FDA. A lot of bureaucracy, a lot of detailed analysis, a lot of nonsense, a lot of delay. I hope Abeo connects with new people and can shorten the eternal wait while Kristal grows and grows. With a Cmarket of 5 billion

User Image edelhead Posted - 3 days ago

$ABEO The company entered into a lease for an additional 16,500 feet of space starting on Jan. 1st. Would they do this if they weren't confident about the likelihood of FDA approval? Sounds pretty bullish to me!

User Image CliffordCapital Posted - 3 days ago

$ABEO jumped in again.

User Image edelhead Posted - 4 days ago

$ABEO I listened to the Stifel talk; sounded great! Nothing new to report, but I did get the feeling that there is expectation for approval before late April.

User Image edelhead Posted - 4 days ago

$ABEO I have to correct myself. There is one FDA approved Rett treatment (approved in 2023) called Daybue from Acadia. As someone pointed out on yahoo finance today, Acadia received a priority review voucher at the time of the approval; they sold that voucher this month for a whopping $150 million! Abeo is in line to receive a voucher too!!

User Image Tdorsey1776 Posted - 4 days ago

$ABEO Its simply time....patience.

User Image savvy_1 Posted - 4 days ago

$ABEO 5.70 was old resistance now it’s support. Need close to stay above

User Image edelhead Posted - 4 days ago

$ABEO The stars are really starting to align for Abeo: (1) FDA approval coming by April in RDEB; (2) the world's first Sanfilippo treatment, previously licensed by Abeo to Ultragenyx, is being submitted to FDA around year-end for accelerated approval; (3) the world's first Rett treatment, previously licensed by Abeo to Taysha, just took the lead against Neurogene's competing treatment (see Neurogene's press release this morning); Taysha is all-in on Rett (it's their only active program) and the analysts are all on board.

User Image Hounddoggie Posted - 5 days ago

$ABEO Maybe TIL therapy will help them one day...

User Image edelhead Posted - 6 days ago

$ABEO medical stocks got clobbered the last two days because of the RFK, Jr. nomination. But Abeo was the perverbial baby being thrown out with the bathwater. RFK wants the FDA to focus on chronic conditions that negatively impact a person's quality of life on an ongoing basis. RDEB is a condition which fits that description perfectly, so the future for Abeo is still rosy as ever! I expect the stock to rebound accordingly.

User Image donutfish Posted - 1 week ago

$ABEO all they need now is competent IR people

User Image invest2021_now Posted - 1 week ago

$ABEO

User Image edelhead Posted - 1 week ago

$ABEO on Linkedin, Abeo has 10 listings for job openings. This sounds like a company that is expecting FDA approval in April or sooner!

User Image edelhead Posted - 1 week ago

$ABEO I just listened to the audio replay of this morning's conference call; great questions from the analysts and great answers from management. My favorite part - a floor of $1.5 million per treatment! And could be even higher than that!!

User Image RDeneronow Posted - 1 week ago

$ABEO LoL

User Image type12 Posted - 1 week ago

$ABEO Be nice to get it approved before the FDA gets taken over by the crazies.

User Image Ukmc Posted - 1 week ago

$ABEO resubmitted date in the diary - unsure for the price drop were people expecting the FDA to reconvene tomorrow ?

User Image RDeneronow Posted - 1 week ago

$ABEO Good E/R, very positive 🔥 https://investors.abeonatherapeutics.com/press-releases/detail/295/abeona-therapeutics-reports-third-quarter-2024-financial

User Image type12 Posted - 1 week ago

$ABEO April 25/ I believe it can happen earlier/ correct me if I’m wrong. It wasn’t a problem with the treatment.

User Image invest2021_now Posted - 1 week ago

$ABEO MM's lol. Thanks for the cheapies.

Analyst Ratings
HC Wainwright & Co. Buy Aug 14, 24
HC Wainwright & Co. Buy Jul 12, 24
HC Wainwright & Co. Buy Jul 3, 24
Stifel Buy May 30, 24
Cantor Fitzgerald Overweight May 16, 24
Cantor Fitzgerald Overweight Apr 23, 24
Cantor Fitzgerald Overweight Aug 24, 23
Cantor Fitzgerald Overweight Jul 13, 23
Alliance Global Partners Buy May 24, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Alvino Mark Director Director Sep 27 Sell 3.9145 6,316 24,724 69,900 09/29/23
Charles Faith L. Director Director Sep 27 Sell 4.9128 8,330 40,924 70,773 09/29/23
Alland Leila Director Director Sep 27 Sell 3.9014 7,246 28,270 71,857 09/29/23
Amoroso Michael Director Director Sep 27 Sell 3.9111 5,508 21,542 108,957 09/29/23
Seshadri Vishwas Chief Executive Offi.. Chief Executive Officer Sep 27 Buy 4.07 20,000 81,400 521,731 09/29/23
Vazzano Joseph Walter Chief Financial Offi.. Chief Financial Officer Sep 19 Buy 3.76 3,000 11,280 238,179 09/20/23
O'Malley Brendan M. SVP, General Counsel SVP, General Counsel Sep 18 Buy 3.80 3,000 11,400 187,421 09/19/23
Amoroso Michael Director Director Mar 20 Sell 2.33 268 624 56,441 03/21/23
Vazzano Joseph Walter Chief Financial Offi.. Chief Financial Officer Nov 18 Buy 4.00 2,500 10,000 95,250 11/21/22
O'Malley Brendan M. SVP, General Counsel SVP, General Counsel Nov 18 Buy 3.99 7,500 29,925 87,961 11/21/22
O'Malley Brendan M. SVP, General Counsel SVP, General Counsel Oct 05 Sell 1.05 25,210 26,470 248,244 10/08/21
- - - Jan 19 Sell 2.03 320,000 649,600 11,599,292 01/19/21
Mann Paul Elliot Director Director Jan 05 Sell 1.54 30,488 46,952 132,664 01/05/21